Reviews - 7lpd mentioned but not cited (2)
- Ligand-Binding Sites in Vanilloid-Subtype TRP Channels. Yelshanskaya MV, Sobolevsky AI. Front Pharmacol 13 900623 (2022)
- A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel. Amaya-Rodriguez CA, Carvajal-Zamorano K, Bustos D, Alegría-Arcos M, Castillo K. Front Pharmacol 14 1251061 (2023)
Articles - 7lpd mentioned but not cited (3)
Reviews citing this publication (21)
- TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Zhang M, Ma Y, Ye X, Zhang N, Pan L, Wang B. Signal Transduct Target Ther 8 261 (2023)
- TRP channels: a journey towards a molecular understanding of pain. Rosenbaum T, Morales-Lázaro SL, Islas LD. Nat Rev Neurosci 23 596-610 (2022)
- Sensory TRP Channels in Three Dimensions. Diver MM, Lin King JV, Julius D, Cheng Y. Annu Rev Biochem 91 629-649 (2022)
- Capsaicin and TRPV1 Channels in the Cardiovascular System: The Role of Inflammation. Munjuluri S, Wilkerson DA, Sooch G, Chen X, White FA, Obukhov AG. Cells 11 18 (2021)
- A molecular perspective on identifying TRPV1 thermosensitive regions and disentangling polymodal activation. Luu DD, Owens AM, Mebrat MD, Van Horn WD. Temperature (Austin) 10 67-101 (2023)
- Progress in the Structural Basis of thermoTRP Channel Polymodal Gating. Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. Int J Mol Sci 24 743 (2023)
- The Promise of Niacin in Neurology. Wuerch E, Urgoiti GR, Yong VW. Neurotherapeutics 20 1037-1054 (2023)
- A bibliometrics analysis and visualization study of TRPV1 channel. Gao N, Li M, Wang W, Liu Z, Guo Y. Front Pharmacol 14 1076921 (2023)
- Cryo-EM Analyses Permit Visualization of Structural Polymorphism of Biological Macromolecules. Chang WH, Huang SH, Lin HH, Chung SC, Tu IP. Front Bioinform 1 788308 (2021)
- Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms. Huang J, Korsunsky A, Yazdani M, Chen J. Front Mol Neurosci 16 1334370 (2023)
- Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development. Hwang SM, Jo YY, Cohen CF, Kim YH, Berta T, Park CK. Int J Mol Sci 23 5772 (2022)
- Dilation of ion selectivity filters in cation channels. Huffer K, Tan XF, Fernández-Mariño AI, Dhingra S, Swartz KJ. Trends Biochem Sci 49 417-430 (2024)
- Transient Receptor Potential Channels: Multiple Modulators of Peripheral Neuropathic Pain in Several Rodent Models. Xu S, Wang Y. Neurochem Res 49 872-886 (2024)
- Binding interactions of fatty acyl lipid mediators within the vanilloid pocket of TRPV1: A molecular dynamics study. Birkic N, Visentin D, Svedružić Ž, Reynolds CA. Prostaglandins Other Lipid Mediat 169 106771 (2023)
- Capsaicin: a spicy way in liver disease. Li S, Hao L, Yu F, Li N, Deng J, Zhang J, Xiong S, Hu X. Front Pharmacol 15 1451084 (2024)
- Comprehensive review on the novel immunotherapy target: Leucine-rich repeat-containing 8A/volume-regulated anion channel. Hu Y, Qin J, Ma Y, Yang R, Liu X, Shi C. Int J Biol Sci 20 3881-3891 (2024)
- Research focus and thematic trends of transient receptor potential vanilloid member 1 research: a bibliometric analysis of the global publications (1990-2023). Liu X, Zhang M, He C, Jia S, Xiang R, Xu Y, Zhao M. Naunyn Schmiedebergs Arch Pharmacol 397 1327-1346 (2024)
- TRPV2: a universal regulator in cellular physiology with a yet poorly defined thermosensitivity. Fricke TC, Leffler A. J Physiol Sci 74 42 (2024)
- The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization. Gao N, Li M, Wang W, Liu Z, Guo Y. Front Mol Neurosci 17 1400118 (2024)
- Thermal illusions for thermal displays: a review. Karmakar S, Kesh A, Muniyandi M. Front Hum Neurosci 17 1278894 (2023)
- Vertebrate behavioral thermoregulation: knowledge and future directions. Cutler B, Haesemeyer M. Neurophotonics 11 033409 (2024)